PHILADELPHIA—Officials from the U.S. Food & Drug Administration discussed recent drug approvals and drug safety issues at ACR Convergence in November in a session that captured the flurry of activity in the rheumatology sphere at the agency over the past year. Sabiha Khan, MD, clinical reviewer in the Division of Rheumatology and Transplant Medicine at…
Mitigating Drug Shortages: FDA Officials Say Communication Is Crucial
PHILADELPHIA—The most vital component of avoiding drug shortages is early communication, officials from the U.S. Food & Drug Administration (FDA) said in a session at ACR Convergence 2022 in November. “Early notification is key in order to prevent and mitigate shortages,” said Hyun Son, PharmD, a member of the Drug Shortage Staff with the FDA…

Tuhina Neogi, MD, PhD, Returns to Lead the Committee on Quality of Care
Dr. Neogi has returned to the ACR Committee on Quality of Care as its new chair after years of dedicated work developing classification criteria, outcome measures and treatment guidelines for rheumatoid arthritis, gout and other rheumatic diseases.

Are You Listening? Young Patient Advocates Call for Change
PHILADELPHIA—Representatives of the Young Patients’ Autoimmune Research and Empowerment Alliance (YP AREA) led a panel titled Young Patients with Big Ideas Will Revolutionize Healthcare and Research, in which they discussed their work as advocates for adolescent and young adult (AYA) patients. YP AREA’s mission is to make autoimmune research more accessible and inclusive by involving…

Contraception, Abortion & Rheumatic Disease after Dobbs
PHILADELPHIA—As rheumatologists, we care for patients who may or may not want to become pregnant. We aren’t obstetricians or gynecologists, but several of the drugs we prescribe for active rheumatic disease can negatively affect pregnancy outcomes. It’s imperative we understand how to effectively counsel our patients with rheumatic disease on the risks and benefits of…

Rheum After 5: Finding the Balance
When he was a boy, Jeff Peterson, MD, fondly remembers that he would help his dad pick blackberries and watch intently as the berries were transformed into wine. “I liked it when my dad offered me a sip because the wine tasted very sweet,” Dr. Peterson says. “It was a special family moment.” These days,…

Fall 2022’s Awards, Appointments & Announcements in Rheumatology
Lupus Research Alliance Inaugurates Diversity Awards The Lupus Research Alliance (LRA) inaugurated two new award mechanisms this past summer with the goal of alleviating the racial disparities prevalent in both autoimmune diseases and the biomedical research community. Three notable early career scientists from under-represented groups received the Diversity in Lupus Research Career Development Awards, and…

The 2022 ACR Masters
Recognition as an ACR Master is one of the highest honors the College bestows. The designation of Master is conferred on ACR members, age 65 or older by Oct. 1 of the year in which they are nominated, who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or…

The 2022 ACR Awards of Distinction
During ACR Convergence 2022 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care by announcing the recipients of the ACR’s 2022 Awards of Distinction, as well as the 2022 ACR Masters, recognized for their contributions to the field. See the November issue…

The History of The Rheumatologist
The Rheumatologist (TR) premiered in 2006, with its first full year of publication in 2007. In the 15 years since, it has sought to provide clinicians, researchers and healthcare providers with the most stimulating and educational content found in the field of rheumatology. The responsibility for achieving this mission has been borne by just three…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 227
- Next Page »